Kamei Daisuke

Researcher

基本情報

Profile and Settings

• 氏名

  Kamei Daisuke

Affiliation

• Office of Pharmaceutical Education, Associate Professor

Location

• Hatanodai Campus

Degree

• Doctor of Pharmaceutical Science, Showa University, Mar. 2005

Achievements

Published Papers

• Examining the effects of active learning using “Karuta” on memory., Motonori Fukumura, Yuzuka Okahisa, Tsuyoshi Maruyama, Aya Kobayashi, Hitomi Yamamoto, Rina Kato, Daisuke Kamei, Yasuna Kobayashi, 応用薬理, 105(3/4):89 - 92, Dec. 2023, Peer-reviewed
• Evaluation of corneal damage caused by the anticancer drug S-1 in human corneal epithelial cells, MORIYA Kanae;SHIMIZU Hisanori;KAMEI Daisuke;HANDA Satoko;SASAKI Tadanori;KATO Yasuhisa, Showa Univ J Med Sci, 34(1):27 - 32, Mar. 2022, Peer-reviewed
• Gene deletion of microsomal prostaglandin E synthase-1 suppresses chemically induced skin carcinogenesis., SASAKI Yuka;KUWATA Hiroshi;AIDA Eri;OCHIAI Tsubasa;KAMEI Daisuke;NAKATANI Yoshihito;HARA Shuntaro, Anticancer Res, 41(3):1307 - 1314, Mar. 2021, Peer-reviewed
• Effect of intraoral antioxidative capacity in orengedokuto, NISHIJIMA Hiroaki;TAKAMATSU Satoshi;SATOH Kazue;MURASE Remi;TAKI Iori;KAMEI Daisuke;KAWAZOE Kazuyoshi;NEMOTO Yukio;IWAI Shinichi, Tradit Kampo Med, 7(1):30 - 37, Apr. 2020, Peer-reviewed
• Five Prognostic Factors for Readmission in Patients Over 75 Years Old with Worsening Heart Failure, SAITO HIROSHI;SHOJI Makoto;TAKI Iori;MURASE Remi;KAMEI Daisuke;SHINKE Toshiro;IWAI Shinichi, Showa Univ J Med Sci, 32(1):33 - 42, Apr. 2020, Peer-reviewed
• Oxaliplatin induces prostaglandin E2 release in vascular endothelial cells, MATSUNUMA Satoru;HANDA Satoko;KAMEI Daisuke;YAMAMOTO Hitomi;OKUYAMA Kiyoshi;KATO Yasuhisa, Cancer Chemother Pharmacol, 84(2):345 - 350, Aug. 2019, Peer-reviewed
• Risk of Drug-Induced Accidents and Injuries in Elderly Patients Treated with Specific Drugs Rather than Polypharmacy : Analyses of the Japanese Adverse Drug Event Report Database, HAGA Tomohiro;TAKI-TAKEMOTO Iori;MURASE Remi;KAMEI Daisuke;IWAI Shinichi, Showa Univ J Med Sci, 31(2):125 - 137, Jun. 2019, Peer-reviewed
• Anti-inflammatory effects of new catechin derivatives in a hapten-induced mouse contact dermatitis model., NAKANO Eriko;KAMEI Daisuke;MURASE Remi;TAKI Iori;KARASAWA Koji;FUKUHARA Kiyoshi;IWAI Shinichi, Eur J Pharmacol, 845:40 - 47, Feb. 2019, Peer-reviewed
• Coadministration of cytotoxic chemotherapeutic agents with irinotecan is a risk factor for irinotecan-induced cholinergic syndrome in Japanese patients with cancer., TSUBOYA Ayako;FUJITA Ken-ichi;KUBOTA Yutaro;ISHIDA Hiroo;TAKI (TAKEMOTO) Iori;KAMEI Daisuke;IWAI Shinichi;SASAKI Yasutsuna, Int J Clin Oncol, 24(2):222 - 230, Feb. 2019, Peer-reviewed
• KRAS and EGFR Amplifications Mediate Resistance to Rociletinib and Osimertinib in Acquired Afatinib-Resistant NSCLC Harboring Exon 19 Deletion/T790M in EGFR., NAKATANI Kaori;YAMAOKA Toshimitsu;OHBA Motoi;FUJITA Ken-ichi;ARATA Satoru;KUSUMOTO Sojiro;TAKI (TAKEMOTO) Iori;KAMEI Daisuke;IWAI Shinichi;TSURUTANI Junji;OHMORI Tohru, Mol Cancer Ther, 18(1):112 - 126, Jan. 2019, Peer-reviewed
• KRAS and EGFR amplifications mediate resistance to rociletinib and osimertinib in acquired afatinib-resistant NSCLC harboring exon 19 deletion/T790M in EGFR., Nakatani K; Yamaoka T; Ohba M; Fujita KI; Arata S; Kusumoto S; Taki-Takemoto I; Kamei D; Iwai S; Tsurutani J; Ohmori T, Molecular cancer therapeutics, 18(1):112 - 126, Oct. 2018
• KRAS and EGFR amplifications mediate resistance to rociletinib and osimertinib in acquired afatinib-resistant NSCLC harboring exon 19 deletion/T790M in EGFR., Nakatani K; Yamaoka T; Ohba M; Fujita KI; Arata S; Kusumoto S; Taki-Takemoto I; Kamei D; Iwai S; Tsurutani J; Ohmori T, Molecular cancer therapeutics, 18(1):112 - 126, Oct. 2018
• KRAS and EGFR amplifications mediate resistance to rociletinib and osimertinib in acquired afatinib-resistant NSCLC harboring exon 19 deletion/T790M in EGFR., Nakatani K; Yamaoka T; Ohba M; Fujita KI; Arata S; Kusumoto S; Taki-Takemoto I; Kamei D; Iwai S; Tsurutani J; Ohmori T, Molecular cancer therapeutics, 18(1):112 - 126, Oct. 2018
• Coadministration of cytotoxic chemotherapeutic agents with irinotecan is a risk factor for irinotecan-induced cholinergic syndrome in Japanese patients with cancer., Tsuboya A; Fujita KI; Kubota Y; Ishida H; Taki-Takemoto I; Kamei D; Iwai S; Sasaki Y, International journal of clinical oncology, 24(2):222 - 230, Sep. 2018
• Coadministration of cytotoxic chemotherapeutic agents with irinotecan is a risk factor for irinotecan-induced cholinergic syndrome in Japanese patients with cancer., Tsuboya A; Fujita KI; Kubota Y; Ishida H; Taki-Takemoto I; Kamei D; Iwai S; Sasaki Y, International journal of clinical oncology, 24(2):222 - 230, Sep. 2018
• Coadministration of cytotoxic chemotherapeutic agents with irinotecan is a risk factor for irinotecan-induced cholinergic syndrome in Japanese patients with cancer., Tsuboya A; Fujita KI; Kubota Y; Ishida H; Taki-Takemoto I; Kamei D; Iwai S; Sasaki Y, International journal of clinical oncology, 24(2):222 - 230, Sep. 2018
• Cost-minimization analysis of adjuvant chemotherapy regimens given to patients with colorectal cancer in Japan., TAKATA Kosuke;FUJITA Ken-ichi;KUBOTA Yutaro;ISHIDA Hiroo;ICHIKAWA Wataru;SHIMADA Ken;SEKIKAWA Takashi;TAKI-TAKEMOTO Iori;KAMEI Daisuke;IWAI Shinichi;SASAKI Yasutsuna, J Pharm Health Care Sci, 2(30):1 - 9, Nov. 2016, Peer-reviewed
• Assessment of Injection Site Reactions for Peripheral Intravenous Oxaliplatin Infusion and Potential Remedies, HANDA Satoko;KUROIWA Rhohei;MIYANO Masahiro;SHIMIZU Hisanori;KAMEI Daisuke;TAKEI Hiromi;SONOU Hiroko;YAMAMOTO Hitomi;MURAYAMA Jun-Ichiro;SATO Atsushi;KATO Yasuhisa, 癌と化学療法, 43(8):985 - 988, Aug. 2016, Peer-reviewed
• 帯状疱疹関連痛に対するミルタザピンの効果, 武冨　麻恵;信太　賢治;大嶽　浩司;泉山　舞;山元　俊憲;蜂須　貢;増田　豊;亀井　大輔, 昭和学士会雑誌, 76(4):514 - 519, Aug. 2016, Peer-reviewed, DOI:10.14930/jshowaunivsoc.76.514
• Cost-minimization analysis of adjuvant chemotherapy regimens given to patients with colorectal cancer in Japan., Takata K; Fujita KI; Kubota Y; Ishida H; Ichikawa W; Shimada K; Sekikawa T; Taki-Takemoto I; Kamei D; Iwai S; Sasaki Y, Journal of pharmaceutical health care and sciences, 2:30 - 30, 2016
• Cost-minimization analysis of adjuvant chemotherapy regimens given to patients with colorectal cancer in Japan., Takata K; Fujita KI; Kubota Y; Ishida H; Ichikawa W; Shimada K; Sekikawa T; Taki-Takemoto I; Kamei D; Iwai S; Sasaki Y, Journal of pharmaceutical health care and sciences, 2:30 - 30, 2016
• 末梢性顔面神経麻痺の難治化と予後因子 , 亀井　大輔;滝(竹本)　伊織;増田　豊;岩井　信市, 昭和学士会雑誌, 75(3):283 - 287, Jun. 2015, Peer-reviewed, DOI:10.14930/jshowaunivsoc.75.283
• 薬剤師による臨床判断能力の習得を目指した参加型研修とその検証, 鈴木　千佳;亀井　大輔;木内　祐二, アプライド・セラピューティクス, 6(1):70 - 80, Sep. 2014, Peer-reviewed
• Microsomal prostaglandin E synthase-1 is induced in alzheimer's disease and its deletion mitigates alzheimer's disease-like pathology in a mouse model, Yoshiharu Akitake; Yoshihito Nakatani; Daisuke Kamei; Masato Hosokawa; Hiroyasu Akatsu; Satoshi Uematsu; Shizuo Akira; Ichiro Kudo; Shuntaro Hara; Mitsuo Takahashi, JOURNAL OF NEUROSCIENCE RESEARCH, 91(7):909 - 919, Jul. 2013
• Microsomal prostaglandin E synthase-1 is induced in alzheimer's disease and its deletion mitigates alzheimer's disease-like pathology in a mouse model, Yoshiharu Akitake; Yoshihito Nakatani; Daisuke Kamei; Masato Hosokawa; Hiroyasu Akatsu; Satoshi Uematsu; Shizuo Akira; Ichiro Kudo; Shuntaro Hara; Mitsuo Takahashi, JOURNAL OF NEUROSCIENCE RESEARCH, 91(7):909 - 919, Jul. 2013
• 患者の本音や期待の把握を目指した「コミュニケーション・服薬説明実習」の取り組み, 神山　紀子;松江　みどり;亀井　大輔;大林　真幸;赤川　圭子;井手口　直子;山元　俊憲, 日本ファーマシューティカルコミュニケーション学会会誌, 11(1):33 - 42, Apr. 2013, Peer-reviewed
• Advanced Curriculum for Clinical Assessment and Skill in New Age Pharmacist Education, Yuji Kiuchi; Yutaka Masuda; Daisuke Kamei; Mari Kogo; Akihiro Nakamura, YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 133(2):231 - 241, Feb. 2013
• Advanced Curriculum for Clinical Assessment and Skill in New Age Pharmacist Education, Yuji Kiuchi; Yutaka Masuda; Daisuke Kamei; Mari Kogo; Akihiro Nakamura, YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 133(2):231 - 241, Feb. 2013
• Deletion of microsomal prostaglandin E synthase-1 protects neuronal cells from cytotoxic effects of beta-amyloid peptide fragment 31-35, Yukiko Kuroki; Yuka Sasaki; Daisuke Kamei; Yoshiharu Akitake; Mitsuo Takahashi; Satoshi Uematsu; Shizuo Akira; Yoshihito Nakatani; Ichiro Kudo; Shuntaro Hara, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 424(3):409 - 413, Aug. 2012
• Deletion of microsomal prostaglandin E synthase-1 protects neuronal cells from cytotoxic effects of beta-amyloid peptide fragment 31-35, Yukiko Kuroki; Yuka Sasaki; Daisuke Kamei; Yoshiharu Akitake; Mitsuo Takahashi; Satoshi Uematsu; Shizuo Akira; Yoshihito Nakatani; Ichiro Kudo; Shuntaro Hara, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 424(3):409 - 413, Aug. 2012
• Deletion of microsomal prostaglandin E synthase-1 protects neuronal cells from cytotoxic effects of beta-amyloid peptide fragment 31-35, Yukiko Kuroki; Yuka Sasaki; Daisuke Kamei; Yoshiharu Akitake; Mitsuo Takahashi; Satoshi Uematsu; Shizuo Akira; Yoshihito Nakatani; Ichiro Kudo; Shuntaro Hara, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 424(3):409 - 413, Aug. 2012, Peer-reviewed
• Microsomal prostaglandin E synthase-1 is involved in multiple steps of colon carcinogenesis, Y. Sasaki; D. Kamei; Y. Ishikawa; T. Ishii; S. Uematsu; S. Akira; M. Murakami; S. Hara, ONCOGENE, 31(24):2943 - 2952, Jun. 2012
• Microsomal prostaglandin E synthase-1 is involved in multiple steps of colon carcinogenesis, Y. Sasaki; D. Kamei; Y. Ishikawa; T. Ishii; S. Uematsu; S. Akira; M. Murakami; S. Hara, ONCOGENE, 31(24):2943 - 2952, Jun. 2012
• Analysis of Two Major Intracellular Phospholipases A(2) (PLA(2)) in Mast Cells Reveals Crucial Contribution of Cytosolic PLA(2)alpha, Not Ca2+-independent PLA(2)beta, to Lipid Mobilization in Proximal Mast Cells and Distal Fibroblasts, Noriko Ueno; Yoshitaka Taketomi; Kei Yamamoto; Tetsuya Hirabayashi; Daisuke Kamei; Yoshihiro Kita; Takao Shimizu; Koei Shinzawa; Yoshihide Tsujimoto; Kazutaka Ikeda; Ryo Taguchi; Makoto Murakamia, JOURNAL OF BIOLOGICAL CHEMISTRY, 286(43):37249 - 37263, Oct. 2011
• Analysis of Two Major Intracellular Phospholipases A(2) (PLA(2)) in Mast Cells Reveals Crucial Contribution of Cytosolic PLA(2)alpha, Not Ca2+-independent PLA(2)beta, to Lipid Mobilization in Proximal Mast Cells and Distal Fibroblasts, Noriko Ueno; Yoshitaka Taketomi; Kei Yamamoto; Tetsuya Hirabayashi; Daisuke Kamei; Yoshihiro Kita; Takao Shimizu; Koei Shinzawa; Yoshihide Tsujimoto; Kazutaka Ikeda; Ryo Taguchi; Makoto Murakamia, JOURNAL OF BIOLOGICAL CHEMISTRY, 286(43):37249 - 37263, Oct. 2011
• Physiological Roles of Group X-secreted Phospholipase A(2) in Reproduction, Gastrointestinal Phospholipid Digestion, and Neuronal Function, Hiroyasu Sato; Yuki Isogai; Seiko Masuda; Yoshitaka Taketomi; Yoshimi Miki; Daisuke Kamei; Shuntaro Hara; Tetsuyuki Kobayashi; Yukio Ishikawa; Toshiharu Ishii; Kazutaka Ikeda; Ryo Taguchi; Yoshikazu Ishimoto; Noriko Suzuki; Yasunori Yokota; Kohji Hanasaki; Toshiko Suzuki-Yamamoto; Kei Yamamoto; Makoto Murakami, JOURNAL OF BIOLOGICAL CHEMISTRY, 286(13):11632 - 11648, Apr. 2011
• Physiological Roles of Group X-secreted Phospholipase A(2) in Reproduction, Gastrointestinal Phospholipid Digestion, and Neuronal Function, Hiroyasu Sato; Yuki Isogai; Seiko Masuda; Yoshitaka Taketomi; Yoshimi Miki; Daisuke Kamei; Shuntaro Hara; Tetsuyuki Kobayashi; Yukio Ishikawa; Toshiharu Ishii; Kazutaka Ikeda; Ryo Taguchi; Yoshikazu Ishimoto; Noriko Suzuki; Yasunori Yokota; Kohji Hanasaki; Toshiko Suzuki-Yamamoto; Kei Yamamoto; Makoto Murakami, JOURNAL OF BIOLOGICAL CHEMISTRY, 286(13):11632 - 11648, Apr. 2011
• Prostaglandin E synthases: Understanding their pathophysiological roles through mouse genetic models, Shuntaro Hara; Daisuke Kamei; Yuka Sasaki; Akemi Tanemoto; Yoshihito Nakatani; Makoto Murakami, BIOCHIMIE, 92(6):651 - 659, Jun. 2010
• Prostaglandin E synthases: Understanding their pathophysiological roles through mouse genetic models, Shuntaro Hara; Daisuke Kamei; Yuka Sasaki; Akemi Tanemoto; Yoshihito Nakatani; Makoto Murakami, BIOCHIMIE, 92(6):651 - 659, Jun. 2010
• Microsomal prostaglandin E synthase-1 in both cancer cells and hosts contributes to tumour growth, invasion and metastasis, Daisuke Kamei; Makoto Murakami; Yuka Sasaki; Yoshihito Nakatani; Masataka Majima; Yukio Ishikawa; Toshiharu Ishii; Satoshi Uematsu; Shizuo Akira; Shuntaro Hara; Ichiro Kudo, BIOCHEMICAL JOURNAL, 425(2):361 - 371, Jan. 2010
• Microsomal prostaglandin E synthase-1 in both cancer cells and hosts contributes to tumour growth, invasion and metastasis, Daisuke Kamei; Makoto Murakami; Yuka Sasaki; Yoshihito Nakatani; Masataka Majima; Yukio Ishikawa; Toshiharu Ishii; Satoshi Uematsu; Shizuo Akira; Shuntaro Hara; Ichiro Kudo, BIOCHEMICAL JOURNAL, 425(2):361 - 371, Jan. 2010
• Microsomal prostaglandin E synthase-1 (mPGES-1) deficiency suppresses chemical carcinogen-induced colon carcinogenesis, Yuka Sasaki; Daisuke Kamei; Yukio Ishikawa; Toshiharu Ishii; Shuntaro Hara, CHEMISTRY AND PHYSICS OF LIPIDS, 160:S25 - S25, Aug. 2009
• Microsomal prostaglandin E synthase-1 (mPGES-1) deficiency suppresses chemical carcinogen-induced colon carcinogenesis, Yuka Sasaki; Daisuke Kamei; Yukio Ishikawa; Toshiharu Ishii; Shuntaro Hara, CHEMISTRY AND PHYSICS OF LIPIDS, 160:S25 - S25, Aug. 2009
• Association of microsomal prostaglandin E synthase 1 deficiency with impaired fracture healing, but not with bone loss or osteoarthritis, in mouse models of skeletal disorders, Kiyofumi Yamakawa; Satoru Kamekura; Naohiro Kawamura; Masatomo Saegusa; Daisuke Kamei; Makoto Murakami; Ichiro Kudo; Satoshi Uematsu; Shizuo Akira; Ung-Il Chung; Kozo Nakamura; Hiroshi Kawaguchi, ARTHRITIS AND RHEUMATISM, 58(1):172 - 183, Jan. 2008
• Association of microsomal prostaglandin E synthase 1 deficiency with impaired fracture healing, but not with bone loss or osteoarthritis, in mouse models of skeletal disorders, Kiyofumi Yamakawa; Satoru Kamekura; Naohiro Kawamura; Masatomo Saegusa; Daisuke Kamei; Makoto Murakami; Ichiro Kudo; Satoshi Uematsu; Shizuo Akira; Ung-Il Chung; Kozo Nakamura; Hiroshi Kawaguchi, ARTHRITIS AND RHEUMATISM, 58(1):172 - 183, Jan. 2008
• Change in prostaglandin E synthases (PGESs) in microsomal PGES-1 knockout mice in a preterm delivery model, K Kubota; T Kubota; D Kamei; M Murakami; Kudo, I; T Aso; Morita, I, JOURNAL OF ENDOCRINOLOGY, 187(3):339 - 345, Dec. 2005
• Change in prostaglandin E synthases (PGESs) in microsomal PGES-1 knockout mice in a preterm delivery model, K Kubota; T Kubota; D Kamei; M Murakami; Kudo, I; T Aso; Morita, I, JOURNAL OF ENDOCRINOLOGY, 187(3):339 - 345, Dec. 2005
• Coupling between cyclooxygenases and terminal prostanoid synthases, N Ueno; Y Takegoshi; D Kamei; Kudo, I; M Murakami, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 338(1):70 - 76, Dec. 2005
• Coupling between cyclooxygenases and terminal prostanoid synthases, N Ueno; Y Takegoshi; D Kamei; Kudo, I; M Murakami, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 338(1):70 - 76, Dec. 2005
• Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin E synthase-1, D Kamei; K Yamakawa; Y Takegoshi; M Mikami-Nakanishi; Y Nakatani; S Oh-ishi; H Yasui; Y Azuma; N Hirasawa; K Ohuchi; H Kawaguchi; Y Ishikawa; T Ishii; S Uematsu; S Akira; M Murakami; Kudo, I, JOURNAL OF BIOLOGICAL CHEMISTRY, 279(32):33684 - 33695, Aug. 2004
• Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin E synthase-1, D Kamei; K Yamakawa; Y Takegoshi; M Mikami-Nakanishi; Y Nakatani; S Oh-ishi; H Yasui; Y Azuma; N Hirasawa; K Ohuchi; H Kawaguchi; Y Ishikawa; T Ishii; S Uematsu; S Akira; M Murakami; Kudo, I, JOURNAL OF BIOLOGICAL CHEMISTRY, 279(32):33684 - 33695, Aug. 2004
• Cellular prostaglandin E-2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and-2, M Murakami; K Nakashima; D Kamei; S Masuda; Y Ishikawa; T Ishii; Y Ohmiya; K Watanabe; Kudo, I, JOURNAL OF BIOLOGICAL CHEMISTRY, 278(39):37937 - 37947, Sep. 2003
• Cellular prostaglandin E-2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and-2, M Murakami; K Nakashima; D Kamei; S Masuda; Y Ishikawa; T Ishii; Y Ohmiya; K Watanabe; Kudo, I, JOURNAL OF BIOLOGICAL CHEMISTRY, 278(39):37937 - 37947, Sep. 2003
• Coupling between cyclooxygenases and prostaglandin F(2alpha) synthase. Detection of an inducible, glutathione-activated, membrane-bound prostaglandin F(2alpha)-synthetic activity., Nakashima K; Ueno N; Kamei D; Tanioka T; Nakatani Y; Murakami M; Kudo I, Biochimica et biophysica acta, 1633(2):96 - 105, Jul. 2003
• Coupling between cyclooxygenases and prostaglandin F(2alpha) synthase. Detection of an inducible, glutathione-activated, membrane-bound prostaglandin F(2alpha)-synthetic activity., Nakashima K; Ueno N; Kamei D; Tanioka T; Nakatani Y; Murakami M; Kudo I, Biochimica et biophysica acta, 1633(2):96 - 105, Jul. 2003
• Potential role of microsomal prostaglandin E synthase-1 in tumorigenesis, D Kamei; M Murakami; Y Nakatani; Y Ishikawa; T Ishii; Kudo, I, JOURNAL OF BIOLOGICAL CHEMISTRY, 278(21):19396 - 19405, May 2003
• Potential role of microsomal prostaglandin E synthase-1 in tumorigenesis, D Kamei; M Murakami; Y Nakatani; Y Ishikawa; T Ishii; Kudo, I, JOURNAL OF BIOLOGICAL CHEMISTRY, 278(21):19396 - 19405, May 2003

Presentations

• Short-Form McGill Pain Questionnaire 2を用いたプレガバリンの有効性評価, 滝　伊織;村瀬　礼美;亀井　大輔;岩井　信市, 日本薬学会年会要旨集141年会, 27 Mar. 2021, オンライン開催
• Evaluation of corneal damage caused by anticancer drug S-1, 守屋　賀奈絵;清水　久範;亀井　大輔;半田　智子;佐々木　忠徳;加藤　裕久, 日本薬学会第141年会, 27 Mar. 2021, オンライン開催
• Development of a score predicting readmission worsening heart failure in elderly heart failure patients, 齋藤　拓史;正司　真;亀井　大輔;新家　俊郎;岩井　信市, 第23回日本心不全学会学術集会, 05 Oct. 2019, 広島
• 参加型生涯研修プログラムの有用性評価 ―昭和大学薬剤師生涯研修認定制度（H30年度）の検証―, 田中　佐知子;芦野　隆;高松　智;唐沢　浩二;小林　文;亀井　大輔;熊木　良太;阿部　誠治;佐口　健一;加藤　肇;倉田　なおみ;加藤　裕久;中村　明弘, 第4回日本薬学教育学会大会, 24 Aug. 2019, 豊中
• インスリングラルギン注のバイオ後続品切り替えに伴う有効性評価, 岡村　駿人;滝　伊織;坂田　恵利佳;村瀬　礼美;亀井　大輔;岩井　信市, 第62回日本薬学会関東支部大会, 15 Sep. 2018, 東京
• カテキン誘導体化合物によるアレルギー性接触皮膚炎に対するサイトカイン抑制効果, 中野　恵理子;亀井　大輔;村瀬　礼美;滝　伊織;唐沢　浩二;福原　潔;岩井　信市, 第23回日本フードファクター学会・第12回日本ポリフェノール学会・第15回日本カテキン学会合同学術集会, 07 Sep. 2018, 京都
• 参加型生涯研修プログラムの有用性評価－昭和大学薬剤師生涯研修認定制度（平成29年度）の検証－, 芦野　隆;田中　佐知子;亀井　大輔;唐沢　浩二;高松　智;小林　文;阿部　誠治;熊木　良太;佐口　健一;加藤　肇;倉田　なおみ;加藤　裕久;中村　明弘, 第3回日本薬学教育学会大会, 01 Sep. 2018, 東京
• 在宅において多職種連携・協働を実践できる医療人養成のための学部連携教育プログラムの開発と実践　〜高齢者やその家族の思いを主眼としたPBLチュートリアル〜, 福村　基徳;亀井　大輔;大幡　久之;木内　祐二;倉田　知光;田中　一正;片岡　竜太;鈴木　久義;倉田　なおみ;加藤　裕久;中村　明弘, 第11回日本保健医療福祉連携教育学会学術集会, 11 Aug. 2018, 阿見町 (茨城)
• 昭和大学における体系的な学部連携在宅チーム医療教育とPBLチュートリアルのための映像シナリオの開発, 福村　基徳;亀井　大輔;木内　祐二;大幡　久之;倉田　知光;田中　一正;片岡　竜太;鈴木　久義;倉田　なおみ;加藤　裕久;中村　明弘, 第50回日本医学教育学会大会, 04 Aug. 2018, 東京
• Resistance mechanisms to third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in lung adenocarcinoma cells harboring the EGFR-T790M mutation, NAKATANI Kaori;YAMAOKA Toshimitsu;OHMORI Tohru;OHBA Motoi;FUJITA Ken-ichi;TAKI Iori;KAMEI Daisuke;IWAI Shinichi;SASAKI Yasutsuna, 18th World Congress of Basic and Clinical Pharmacology (WCP2018), 05 Jul. 2018, Kyoto
• The anti-inflammatory effects of new catechin derivatives in a hapten-induced mouse contact-dermatitis model, NAKANO Eriko;KAMEI Daisuke;TAKI Iori;KARASAWA Koji;FUKUHARA Kiyoshi;IWAI Shinichi, 18th WORLD CONGRESS OF BASIC AND CLINICAL PHARMACOLOGY, 02 Jul. 2018, Kyoto
• 接触性皮膚炎に対する新規カテキン誘導体の抗炎症効果, 中野　恵理子;亀井　大輔;滝　伊織;唐沢　浩二;福原　潔;岩井　信市, 日本薬学会第138年会, 28 Mar. 2018, 金沢
• Resistance mechanisms to third-generation EGFR TKIs in lung adenocarcinoma harboring EGFR T790M mutation, 中谷　香織;山岡　利光;大森　亨;大場　基;藤田　健一;滝　伊織;亀井　大輔;岩井　信市, 日本薬学会第138年会, 28 Mar. 2018, 金沢
• 接触性皮膚炎に対する新規カテキン誘導体の抗炎症効果, 中野　恵理子;亀井　大輔;福原　潔;岩井　信市, 第64回昭和大学学士会総会, 25 Nov. 2017, 東京
• 参加型生涯研修プログラムの有用性評価 ―昭和大学薬剤師生涯研修認定制度（H28 年度）の検証―, 田中　佐知子;芦野　隆;亀井　大輔;唐沢　浩二;佐口　健一;高松　智;加藤　肇;加藤　裕久;中村　明弘, 第2回日本薬学教育学会大会, 03 Sep. 2017, 名古屋
• 事例検討を用いた在宅チーム医療教育実習指導者養成ワークショップの有効性, 田中　佐知子;佐野　敦彦;平岡　千英;半田　智子;山崎　敦代;倉田　なおみ;亀井　大輔;福村　基徳;小川　路代;篠原　久仁子;佐口　健一;加藤　裕久;中村　明弘, 第49回日本医学教育学会大会, 18 Aug. 2017, 札幌
• 日本における大腸がん術後補助化学療法のレジメン別医療経済評価, 髙田　昂輔;藤田　健一;滝　伊織;亀井　大輔;佐々木　康綱;岩井　信市, 日本薬学会第137年会, 25 Mar. 2017, 仙台
• 大腸がん術後補助化学療法レジメンの医療経済性の検討, 髙田　昂輔;藤田　健一;滝　伊織;亀井　大輔;佐々木　康綱;岩井　信市, 第26回日本医療薬学会年会, 18 Sep. 2016, 京都
• フィジカルアセスメントを目的としたバイタルサイン測定手技取得のための実技試験と評価―バイタルサインからフィジカルアセスメントを行える薬剤師の育成に向けて―, 滝　伊織;亀井　大輔;木内　祐二;岩井　信市, 第1回日本薬学教育学会大会, 28 Aug. 2016, 京都
• NBM(Narrative-based medicine)の基盤教育を目的とした専門職連携PBLチュートリアルのための映像教材の開発と評価, 亀井　大輔;大林　真幸;福村　基徳;田中　佐知子;倉田　知光;田中　一正;木内　祐二;加藤　裕久;中村　明弘, 第9回日本保健医療福祉連携教育学会学術集会, 21 Aug. 2016, 東京
• 昭和大学病院発行の院外処方箋における後発医薬品への変更調剤に関する調査, 竹本　伊織;稲葉　琴美;髙田　昂輔;野田　秀裕;柏原　由佳;亀井　大輔;佐々木　忠徳;岩井　信市, 日本薬学会第136年会, 27 Mar. 2016, 横浜
• 1年次在宅訪問実習の構築と実施 昭和大学在宅チーム医療教育推進プロジェクト, 大林　真幸;小倉　浩;刑部　慶太郎;亀井　大輔;平岡　千英;福村　基徳;田中　佐知子;中村　明弘;木内　祐二;倉田　知光;田中　一正;加藤　裕久;山元　俊憲, 日本薬学会第136年会, 27 Mar. 2016, 横浜
• 在宅医療におけるNBM(narrative-based medicine)の基盤教育を目的としたPBLチュートリアルの実施と評価 昭和大学在宅チーム医療教育推進プロジェクト, 亀井　大輔;大林　真幸;平岡　千英;福村　基徳;田中　佐知子;倉田　知光;田中　一正;中村　明弘;木内　祐二;加藤　裕久;山元　俊憲, 日本薬学会第136年会, 27 Mar. 2016, 横浜
• 学部連携地域医療実習を体験した学生および実習指導者から得られた学習成果と課題 昭和大学在宅チーム医療教育推進プロジェクト, 平岡　千英;倉田　なおみ;田中　佐知子;亀井　大輔;大林　真幸;福村　基徳;田中　一正;倉田　知光;中村　明弘;加藤　裕久;木内　祐二;山元　俊憲, 日本薬学会第136年会, 27 Mar. 2016, 横浜
• 日本人の抗がん薬投与における認知機能評価法の確立に向けた検討, 髙田　昂輔;石井　麻菜;竹本　伊織;亀井　大輔;藤田　健一;佐々木　康綱;岩井　信市, 日本薬学会第136年会, 27 Mar. 2016, 横浜
• 日本人を対象とした認知機能の評価法の検証, 髙田　昂輔;石井　麻菜;竹本　伊織;亀井　大輔;藤田　健一;佐々木　康綱;岩井　信市, 第62回昭和大学学士会総会, 28 Nov. 2015, 東京
• 血管拡張剤アダラートCR錠の後発医薬品変更における有効性・安全性評価, 竹本　伊織;亀井　大輔;髙田　昂輔;秋山　加菜;板橋　祐太;小山田　茜;稲寄　雅夫;岩井　信市, 第6回日本アプライド・セラピューティクス学会学術大会, 22 Aug. 2015, 東京
• 皮膚症状における疾患の推測・トリアージのための効果的な学習方法の検討, 滝　伊織;亀井　大輔;栗原　竜也;木内　祐二;岩井　信市, 日本薬学会第135年会, 26 Mar. 2015, 神戸
• 地域医療に貢献する臨床指導薬剤師の育成プログラム＜3年間の取り組みと有用性に関する報告＞, 山本　仁美;加藤　裕久;沼澤　聡;伊藤　克敏;赤川　圭子;亀井　大輔;半田　智子;大林　真幸;倉田　なおみ;木内　祐二;山元　俊憲, 日本薬学会第135年会, 26 Mar. 2015, 神戸
• オキサリプラチン静脈内投与時の血管痛におけるプロスタグランジンＥ2の関与, 松沼　悟 ;中川　裕紀子;半田　智子;亀井　大輔;川城　丈;黒岩　亮平 ;加藤　裕久, 第57回日本薬学会関東支部大会, 26 Oct. 2013, 東京
• 薬剤師の新たな臨床技能の習得を目指した体験型実習の取り組み, 亀井　大輔;鈴木　千佳;栗原　竜也;向後　麻里;田中　広紀;星　茜;斎藤　勳;渡邊　徹;木内　祐二;増田　豊, 日本薬学会第132年会, 28 Mar. 2012, 札幌